Global Reach Uniphar operates across 180 countries with a global team of over 3,500, presenting a scalable platform for both development and commercialization services. This breadth indicates potential for cross-border pharma collaborations and expanded services for multinational clients.

Integrated Services The Uniphar Pharma division covers Development, Clinical, Access, Medical, Commercial, Distribution and Global Sourcing, enabling end-to-end lifecycle support from early research to market. This presents sales opportunities to offer bundled solutions to clients seeking single-vendor efficiency.

Experience & Size With 57 years of industry experience and partnerships with 200+ multinational clients, Uniphar demonstrates credibility and capability, making it a compelling partner for large biopharma seeking reliable development and regulatory support.

Leadership Expansion Recent hires including a Chief Medical Officer and U.S. leadership expansion signal strengthened capabilities and regional focus, suggesting opportunities to present tailored U.S. regulatory, clinical, and medical affairs services to a growing customer base.

Mid-market Growth Current revenue in the $25M–$50M range places Uniphar in the mid-market segment, presenting doors to scalable, cost-efficient development and clinical services for mid-sized biotechs and specialty pharma seeking comprehensive support without engaging larger CROs.